首页 > 最新文献

Clinical nutrition ESPEN最新文献

英文 中文
Association of adipose tissue activity in cervical regions with weight loss and prognostic survival in gastric cancer patients 胃癌患者颈部脂肪组织活性与体重减轻和预后生存的关系。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-10 DOI: 10.1016/j.clnesp.2025.102901
Jun Han , Diya Sun , Qifeng Yao , Qiulei Xi , Shanjun Tan , Hongyan Yin , Guohao Wu
<div><h3>Background</h3><div>With the application of positron emission tomography-computed tomography (PET-CT) in recent years, studies have found that brown adipose tissue is not only present in infants and hibernating mammals but also persists in the neck regions of adults. Cancer-associated cachexia, a complex metabolic syndrome, is characterized by adipose tissue loss and heightened metabolic activity. Despite the profound impact of cachexia on patient outcomes, research into the metabolic dynamics of brown adipose tissue has been sparse. The objective of this study is to quantify the metabolic activity of adipose tissue in the neck regions of gastric cancer patients using PET-CT and to elucidate the relationship between adipose tissue metabolic activity and cachexia, along with its potential predictive value for survival outcomes.</div></div><div><h3>Methods</h3><div>We collected PET-CT imaging data and 18F-fluorodeoxyglucose (FDG) standardized uptake values from the nuchal adipose tissue of 310 patients diagnosed with gastric cancer. Concurrently, we gathered clinical data from these patients to facilitate a thorough analysis. The t-test was employed to evaluate the FDG uptake differences in nuchal adipose tissue between gastric cancer patients exhibiting cancer cachexia or not. The correlation between FDG uptake of nuchal adipose tissue and clinical indicators, along with weight loss and nutritional status, was further analyzed using Spearman's rank correlation test. Kaplan–Meier curves and Cox Proportional Hazards Model were employed to clarify the survival of gastric cancer patients in different FDG uptake groups.</div></div><div><h3>Results</h3><div>The 310 gastric cancer patients were divided into 103 patients with cachexia and 207 patients without cachexia. Patients with cachexia exhibited a significantly elevated FDG uptake of nuchal adipose tissue compared to those without cachexia (<em>p</em> < 0.05). Furthermore, correlation analyses demonstrated notable inverse relationships between the FDG uptake of nuchal adipose tissue with body mass index and serum albumin concentrations (<em>p</em> < 0.05). We also observed a positive correlation between the FDG uptake of nuchal adipose tissue with both the weight loss ratio and serum concentrations of tumor necrosis factor-alpha (all <em>p</em> < 0.05). Additionally, patients with elevated FDG uptake of nuchal adipose tissue had a significantly lower survival rate compared to those with lower FDG uptake (<em>p</em> = 0.04). Furthermore, FDG uptake in nuchal adipose tissue was an independent prognostic indicator in gastric cancer patients (HR = 1.81, <em>p</em> = 0.03).</div></div><div><h3>Conclusions</h3><div>In gastric patients with cachexia, the metabolic activity of nuchal adipose tissue was significantly elevated and correlated with weight loss, compromised nutritional status, and an unfavorable survival prognosis. This study could provide valuable insights into the pathophysio
背景:近年来随着正电子发射断层扫描-计算机断层扫描(PET-CT)的应用,研究发现棕色脂肪组织不仅存在于婴儿和冬眠哺乳动物中,也存在于成人颈部。癌症相关恶病质是一种复杂的代谢综合征,其特征是脂肪组织损失和代谢活动增加。尽管恶病质对患者预后有深远的影响,但对棕色脂肪组织代谢动力学的研究却很少。本研究的目的是利用PET-CT量化胃癌患者颈部脂肪组织的代谢活性,阐明脂肪组织代谢活性与恶病质之间的关系,以及其对生存结果的潜在预测价值。方法:收集310例胃癌患者颈部脂肪组织的PET-CT影像资料和18f -氟脱氧葡萄糖(FDG)标准化摄取值。同时,我们收集了这些患者的临床数据,以便进行彻底的分析。采用t检验评价有无恶性恶病质的胃癌患者颈脂肪组织FDG摄取的差异。采用Spearman秩相关检验进一步分析颈脂肪组织FDG摄取与临床指标、体重减轻和营养状况的相关性。采用Kaplan-Meier曲线和Cox比例风险模型分析不同FDG摄取组胃癌患者的生存情况。结果:310例胃癌患者分为有恶病质103例和无恶病质207例。与没有恶病质的患者相比,有恶病质的患者颈部脂肪组织的FDG摄取显著增加(p < 0.05)。此外,相关分析显示,颈脂肪组织FDG摄取与体重指数和血清白蛋白浓度呈显著负相关(p < 0.05)。我们还观察到颈脂肪组织FDG摄取与体重减轻率和血清肿瘤坏死因子- α浓度呈正相关(均p < 0.05)。此外,颈脂肪组织FDG摄取量升高的患者生存率明显低于FDG摄取量较低的患者(p = 0.04)。此外,颈脂肪组织FDG摄取是胃癌患者的独立预后指标(HR = 1.81, p = 0.03)。结论:在胃患者恶病质中,颈部脂肪组织代谢活性显著升高,并与体重减轻、营养状况受损和不利的生存预后相关。这项研究可以为恶病质的病理生理学提供有价值的见解,并可能支持有针对性的治疗干预措施的发展。
{"title":"Association of adipose tissue activity in cervical regions with weight loss and prognostic survival in gastric cancer patients","authors":"Jun Han ,&nbsp;Diya Sun ,&nbsp;Qifeng Yao ,&nbsp;Qiulei Xi ,&nbsp;Shanjun Tan ,&nbsp;Hongyan Yin ,&nbsp;Guohao Wu","doi":"10.1016/j.clnesp.2025.102901","DOIUrl":"10.1016/j.clnesp.2025.102901","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;With the application of positron emission tomography-computed tomography (PET-CT) in recent years, studies have found that brown adipose tissue is not only present in infants and hibernating mammals but also persists in the neck regions of adults. Cancer-associated cachexia, a complex metabolic syndrome, is characterized by adipose tissue loss and heightened metabolic activity. Despite the profound impact of cachexia on patient outcomes, research into the metabolic dynamics of brown adipose tissue has been sparse. The objective of this study is to quantify the metabolic activity of adipose tissue in the neck regions of gastric cancer patients using PET-CT and to elucidate the relationship between adipose tissue metabolic activity and cachexia, along with its potential predictive value for survival outcomes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We collected PET-CT imaging data and 18F-fluorodeoxyglucose (FDG) standardized uptake values from the nuchal adipose tissue of 310 patients diagnosed with gastric cancer. Concurrently, we gathered clinical data from these patients to facilitate a thorough analysis. The t-test was employed to evaluate the FDG uptake differences in nuchal adipose tissue between gastric cancer patients exhibiting cancer cachexia or not. The correlation between FDG uptake of nuchal adipose tissue and clinical indicators, along with weight loss and nutritional status, was further analyzed using Spearman's rank correlation test. Kaplan–Meier curves and Cox Proportional Hazards Model were employed to clarify the survival of gastric cancer patients in different FDG uptake groups.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The 310 gastric cancer patients were divided into 103 patients with cachexia and 207 patients without cachexia. Patients with cachexia exhibited a significantly elevated FDG uptake of nuchal adipose tissue compared to those without cachexia (&lt;em&gt;p&lt;/em&gt; &lt; 0.05). Furthermore, correlation analyses demonstrated notable inverse relationships between the FDG uptake of nuchal adipose tissue with body mass index and serum albumin concentrations (&lt;em&gt;p&lt;/em&gt; &lt; 0.05). We also observed a positive correlation between the FDG uptake of nuchal adipose tissue with both the weight loss ratio and serum concentrations of tumor necrosis factor-alpha (all &lt;em&gt;p&lt;/em&gt; &lt; 0.05). Additionally, patients with elevated FDG uptake of nuchal adipose tissue had a significantly lower survival rate compared to those with lower FDG uptake (&lt;em&gt;p&lt;/em&gt; = 0.04). Furthermore, FDG uptake in nuchal adipose tissue was an independent prognostic indicator in gastric cancer patients (HR = 1.81, &lt;em&gt;p&lt;/em&gt; = 0.03).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;In gastric patients with cachexia, the metabolic activity of nuchal adipose tissue was significantly elevated and correlated with weight loss, compromised nutritional status, and an unfavorable survival prognosis. This study could provide valuable insights into the pathophysio","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102901"},"PeriodicalIF":2.6,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145959086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An exploratory, open-label, pilot randomized trial of omega-3 fatty acid supplementation on serum ferritin in university female students: The OMEGA-3 FA study. 一项探索性、开放标签、试点随机试验:omega-3脂肪酸补充对女大学生血清铁蛋白的影响:omega-3脂肪酸研究。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-09 DOI: 10.1016/j.clnesp.2026.102906
Mami Fujibayashi, Akiko Suganuma, Masayuki Domichi, Ikuyo Hayashi, Ryohei Yamakata, Hiroyoshi Fujikawa, Akihito Kumano, Kota Kijima, Sayaka Tomokane, Yukio Ogura, Seiko Sakane, Naoki Sakane

Background: Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have unique properties that are advantageous for female. However, no study has explored the effects of omega-3 PUFA supplementation on serum ferritin levels. Thus, the objective of this study was to investigate the effects of omega-3 PUFA supplementation on serum ferritin levels in university female students.

Methods: Thirty-nine iron-deficient university female students aged 18-29 years randomly assigned in a 1:1 ratio to either the intervention group (receiving 525 mg eicosapentaenoic acid [EPA] and 175 mg docosahexaenoic acid [DHA] daily for 8 weeks) or the control group. Hemoglobin and serum ferritin levels, dietary intake, and lipidomics were assessed at baseline and after the 8-week intervention period. Analyses were performed by an independent, blinded statistician.

Results: The adherence rate in the study was 94.9 %. n-3 PUFA supplementation increased the omega-3 index (1.8 ± 1.7 vs. 0.4 ± 1.1; p = 0.007), while it decreased the omega-6/3 ratio (-2.6 ± 2.5 vs. -0.9 ± 1.5; p = 0.016) and arachidonic acid/EPA ratio (-9.1 ± 11.6 vs. 1.4 ± 8.5; p = 0.004) compared to those in the control group. These supplementation increased serum ferritin levels (7.8 ± 9.1 vs. 1.8 ± 8.0 ng/mL; p = 0.041); however, it did not change hemoglobin and hepcidin levels compared to those in the control group. No adverse events were observed.

Conclusion: In this pilot study, omega-3 PUFA supplementation was associated with modest changes in iron status markers in young healthy females. These findings are exploratory, and further placebo-controlled trials are needed to confirm the effects.

Name of trial registry: The effect of omega-3 fatty acids intake on hepcidin and anemia Identifying number: UMIN000050570.

Date of registration: 2023/03/14.

背景:Omega-3多不饱和脂肪酸(n-3 PUFAs)具有对女性有利的独特特性。然而,没有研究探索omega-3 PUFA补充剂对血清铁蛋白水平的影响。因此,本研究的目的是研究补充omega-3多聚脂肪酸对大学生血清铁蛋白水平的影响。方法:39名18-29岁的缺铁女大学生,按1:1的比例随机分为干预组(每天服用525 mg二十碳五烯酸[EPA]和175 mg二十二碳六烯酸[DHA],持续8周)和对照组。在基线和8周干预期后评估血红蛋白和血清铁蛋白水平、饮食摄入量和脂质组学。分析由独立的盲法统计学家进行。结果:本研究依从率为94.9%。与对照组相比,补充n-3 PUFA增加了omega-3指数(1.8±1.7比0.4±1.1,p = 0.007),同时降低了omega-6/3比率(-2.6±2.5比-0.9±1.5,p = 0.016)和花生四烯酸/EPA比率(-9.1±11.6比1.4±8.5,p = 0.004)。这些补充剂增加了血清铁蛋白水平(7.8±9.1 vs 1.8±8.0 ng/mL, p = 0.041);然而,与对照组相比,它没有改变血红蛋白和hepcidin水平。未观察到不良事件。结论:在这项初步研究中,补充omega-3 PUFA与年轻健康女性铁状态标记物的适度变化有关。这些发现是探索性的,需要进一步的安慰剂对照试验来证实其效果。试验注册名称:摄入omega-3脂肪酸对hepcidin和贫血的影响识别号:UMIN000050570注册日期:2023/03/14。
{"title":"An exploratory, open-label, pilot randomized trial of omega-3 fatty acid supplementation on serum ferritin in university female students: The OMEGA-3 FA study.","authors":"Mami Fujibayashi, Akiko Suganuma, Masayuki Domichi, Ikuyo Hayashi, Ryohei Yamakata, Hiroyoshi Fujikawa, Akihito Kumano, Kota Kijima, Sayaka Tomokane, Yukio Ogura, Seiko Sakane, Naoki Sakane","doi":"10.1016/j.clnesp.2026.102906","DOIUrl":"10.1016/j.clnesp.2026.102906","url":null,"abstract":"<p><strong>Background: </strong>Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have unique properties that are advantageous for female. However, no study has explored the effects of omega-3 PUFA supplementation on serum ferritin levels. Thus, the objective of this study was to investigate the effects of omega-3 PUFA supplementation on serum ferritin levels in university female students.</p><p><strong>Methods: </strong>Thirty-nine iron-deficient university female students aged 18-29 years randomly assigned in a 1:1 ratio to either the intervention group (receiving 525 mg eicosapentaenoic acid [EPA] and 175 mg docosahexaenoic acid [DHA] daily for 8 weeks) or the control group. Hemoglobin and serum ferritin levels, dietary intake, and lipidomics were assessed at baseline and after the 8-week intervention period. Analyses were performed by an independent, blinded statistician.</p><p><strong>Results: </strong>The adherence rate in the study was 94.9 %. n-3 PUFA supplementation increased the omega-3 index (1.8 ± 1.7 vs. 0.4 ± 1.1; p = 0.007), while it decreased the omega-6/3 ratio (-2.6 ± 2.5 vs. -0.9 ± 1.5; p = 0.016) and arachidonic acid/EPA ratio (-9.1 ± 11.6 vs. 1.4 ± 8.5; p = 0.004) compared to those in the control group. These supplementation increased serum ferritin levels (7.8 ± 9.1 vs. 1.8 ± 8.0 ng/mL; p = 0.041); however, it did not change hemoglobin and hepcidin levels compared to those in the control group. No adverse events were observed.</p><p><strong>Conclusion: </strong>In this pilot study, omega-3 PUFA supplementation was associated with modest changes in iron status markers in young healthy females. These findings are exploratory, and further placebo-controlled trials are needed to confirm the effects.</p><p><strong>Name of trial registry: </strong>The effect of omega-3 fatty acids intake on hepcidin and anemia Identifying number: UMIN000050570.</p><p><strong>Date of registration: </strong>2023/03/14.</p>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"102906"},"PeriodicalIF":2.6,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malnutrition risk in hospitalized patients with diabetes mellitus: Prevalence and associated factors as assessed by Nutritional Risk Screening 2002 (NRS-2002) 糖尿病住院患者的营养不良风险:2002年营养风险筛查(NRS-2002)评估的患病率和相关因素
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-09 DOI: 10.1016/j.clnesp.2026.102910
Yanjun Chang , Wenxing Wang , Fengni Jin , Jianhua Li , Xi Wang , Jiazhen Zhang , Yarong Xie

Background and aims

Malnutrition is a common issue among hospitalized diabetic patients, often leading to poor outcomes. The Nutritional Risk Screening 2002 (NRS-2002) is a widely used tool for assessing nutritional risk, but its relevance to diabetic patients and correlation with clinical parameters are unclear. This study aims to assess the prevalence of nutritional risk in hospitalized diabetic patients using NRS-2002, explore its relationship with key clinical indicators, and identify independent factors influencing nutritional risk for better management strategies.

Methods

This single-center retrospective study included 329 diabetic inpatients from the Department of Endocrinology at Yuncheng Central Hospital, affiliated with Shanxi Medical University, between December 2022 and June 2025. Data from the Electronic Medical Record (EMR) and Laboratory Information System (LIS) covered demographics, clinical features, anthropometrics, laboratory parameters (nutritional markers, lipids, pancreatic enzymes, inflammatory and metabolic indicators), and comorbidities. Nutritional risk at admission was assessed using NRS-2002 (score ≥3). Associations with clinical indicators were analyzed using Spearman correlation and logistic regression to identify independent predictors.

Results

Of the 329 patients, 91 (27.7 %) were at nutritional risk. This group had longer hospital stays, a higher proportion of patients with diabetes duration <5 years, lower BMI, prealbumin, and albumin levels, and higher CRP and HbA1c levels. They also had increased infection and ketosis rates. NRS-2002 scores were positively correlated with ketosis (ρ = 0.468), HbA1c (ρ = 0.386), and infection (ρ = 0.236), and negatively correlated with prealbumin (ρ = −0.404), bicarbonate (ρ = −0.240), and BMI (ρ = −0.205). Multivariate logistic regression identified ketosis (OR = 3.714), HbA1c (OR = 1.265), prealbumin (OR = 0.990), and bicarbonate (OR = 0.896) as independent predictors of nutritional risk. The predictive model showed good performance with an AUC of 0.832.

Conclusion

The NRS-2002 tool effectively assesses nutritional risk in hospitalized diabetic patients, with significant correlations to metabolic issues, inflammation, and complications. Low prealbumin, low bicarbonate, high HbA1c, and ketosis were independent predictors of nutritional risk.
背景和目的:营养不良是住院糖尿病患者的常见问题,往往导致预后不良。营养风险筛查2002 (NRS-2002)是一种广泛使用的评估营养风险的工具,但其与糖尿病患者的相关性以及与临床参数的相关性尚不清楚。本研究旨在利用NRS-2002评估住院糖尿病患者营养风险的发生率,探讨其与关键临床指标的关系,找出影响营养风险的独立因素,以便制定更好的营养风险管理策略。方法:选取山西医科大学附属运城中心医院内分泌科于2022年12月至2025年6月住院的329例糖尿病患者为研究对象,进行单中心回顾性研究。来自电子病历(EMR)和实验室信息系统(LIS)的数据涵盖了人口统计学、临床特征、人体测量学、实验室参数(营养标志物、脂质、胰腺酶、炎症和代谢指标)以及合并症。采用NRS-2002评估入院时的营养风险(评分≥3)。采用Spearman相关和logistic回归分析与临床指标的相关性,以确定独立的预测因子。结果:329例患者中有91例(27.7%)存在营养风险。结论:NRS-2002工具可有效评估住院糖尿病患者的营养风险,与代谢问题、炎症和并发症有显著相关性。低前白蛋白、低碳酸氢盐、高糖化血红蛋白和酮症是营养风险的独立预测因子。
{"title":"Malnutrition risk in hospitalized patients with diabetes mellitus: Prevalence and associated factors as assessed by Nutritional Risk Screening 2002 (NRS-2002)","authors":"Yanjun Chang ,&nbsp;Wenxing Wang ,&nbsp;Fengni Jin ,&nbsp;Jianhua Li ,&nbsp;Xi Wang ,&nbsp;Jiazhen Zhang ,&nbsp;Yarong Xie","doi":"10.1016/j.clnesp.2026.102910","DOIUrl":"10.1016/j.clnesp.2026.102910","url":null,"abstract":"<div><h3>Background and aims</h3><div>Malnutrition is a common issue among hospitalized diabetic patients, often leading to poor outcomes. The Nutritional Risk Screening 2002 (NRS-2002) is a widely used tool for assessing nutritional risk, but its relevance to diabetic patients and correlation with clinical parameters are unclear. This study aims to assess the prevalence of nutritional risk in hospitalized diabetic patients using NRS-2002, explore its relationship with key clinical indicators, and identify independent factors influencing nutritional risk for better management strategies.</div></div><div><h3>Methods</h3><div>This single-center retrospective study included 329 diabetic inpatients from the Department of Endocrinology at Yuncheng Central Hospital, affiliated with Shanxi Medical University, between December 2022 and June 2025. Data from the Electronic Medical Record (EMR) and Laboratory Information System (LIS) covered demographics, clinical features, anthropometrics, laboratory parameters (nutritional markers, lipids, pancreatic enzymes, inflammatory and metabolic indicators), and comorbidities. Nutritional risk at admission was assessed using NRS-2002 (score ≥3). Associations with clinical indicators were analyzed using Spearman correlation and logistic regression to identify independent predictors.</div></div><div><h3>Results</h3><div>Of the 329 patients, 91 (27.7 %) were at nutritional risk. This group had longer hospital stays, a higher proportion of patients with diabetes duration &lt;5 years, lower BMI, prealbumin, and albumin levels, and higher CRP and HbA1c levels. They also had increased infection and ketosis rates. NRS-2002 scores were positively correlated with ketosis (ρ = 0.468), HbA1c (ρ = 0.386), and infection (ρ = 0.236), and negatively correlated with prealbumin (ρ = −0.404), bicarbonate (ρ = −0.240), and BMI (ρ = −0.205). Multivariate logistic regression identified ketosis (OR = 3.714), HbA1c (OR = 1.265), prealbumin (OR = 0.990), and bicarbonate (OR = 0.896) as independent predictors of nutritional risk. The predictive model showed good performance with an AUC of 0.832.</div></div><div><h3>Conclusion</h3><div>The NRS-2002 tool effectively assesses nutritional risk in hospitalized diabetic patients, with significant correlations to metabolic issues, inflammation, and complications. Low prealbumin, low bicarbonate, high HbA1c, and ketosis were independent predictors of nutritional risk.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102910"},"PeriodicalIF":2.6,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Admission systemic inflammation predicts swallowing decline in older adults with pulmonary tuberculosis 入院时全身性炎症可预测老年肺结核患者吞咽能力下降。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-09 DOI: 10.1016/j.clnesp.2026.102913
Masayoshi Kakiuchi , Tatsuro Inoue , Hikaru Kobayashi , Aoi Tsukamoto , Gen Nakano , Tetsuya Kakehi , Toshiaki Tanaka , Masamitsu Nishihara

Background & aims

Tuberculosis remains a serious infectious disease worldwide. However, the status of swallowing function in older adults with pulmonary tuberculosis and the impact of systemic inflammation on swallowing decline during hospitalization have not been fully elucidated. We aimed to examine whether systemic inflammation at admission affects swallowing function decline in older patients with pulmonary tuberculosis.

Methods

This was a single-center, retrospective observational study. The inclusion criteria were patients aged ≥65 years with pulmonary tuberculosis who were admitted to a tuberculosis medical institution between April 2021, and November 2022. Systemic inflammation on admission was assessed with the modified Glasgow Prognostic Score (mGPS). The primary outcome was a decline in swallowing function during hospitalization, defined by a decrease in the Functional Oral Intake Scale (FOIS) score. All data, including mGPS and FOIS, were obtained from medical records. Patients were categorized into a “maintenance” group and a “decline” group based on changes in FOIS. Differences in FOIS scores across mGPS categories were also examined. Logistic regression analyses were performed to identify whether systemic inflammation at admission was an independent risk factor for swallowing decline. Model 1 was adjusted for age, BMI, miliary tuberculosis, and SARC-F ≥4; Model 2 was adjusted for age, miliary tuberculosis, and malnutrition.

Results

A total of 119 patients were included in the analysis. During hospitalization, 31 patients (26.1 %) experienced a decline in swallowing function. Compared with the maintenance group, the decline group was significantly older and showed higher mGPS scores, lower serum albumin, lower Geriatric Nutritional Risk Index values, smaller calf circumference, lower walking ability, and lower FOIS scores at discharge. FOIS scores at both admission and discharge significantly differed across mGPS categories (p < 0.01). The prevalence of dysphagia, defined as FOIS ≤5, was 12.6 % (n = 15) at admission and 19.3 % (n = 23) at discharge. Logistic regression analysis revealed that higher mGPS at admission was independently associated with swallowing decline during hospitalization in both Model 1 (odds ratio 2.81, 95 % confidence interval 1.28–7.83) and Model 2 (odds ratio 2.77, 95 % confidence interval 1.23–7.71).

Conclusion

Systemic inflammation at admission was associated with the development of dysphagia during hospitalization among older adults with pulmonary tuberculosis. Moreover, the prevalence of dysphagia increased from 12.6 % at admission to 19.3 % at discharge.
背景与目的:结核病在世界范围内仍然是一种严重的传染病。然而,老年人肺结核患者的吞咽功能状况以及住院期间全身性炎症对吞咽功能下降的影响尚未完全阐明。我们的目的是研究入院时的全身性炎症是否会影响老年肺结核患者的吞咽功能下降。方法:这是一项单中心、回顾性观察性研究。纳入标准为2021年4月至2022年11月期间在结核病医疗机构就诊的年龄≥65岁的肺结核患者。采用改良的格拉斯哥预后评分(mGPS)评估入院时的全身性炎症。主要结局是住院期间吞咽功能下降,定义为功能性口服摄入量表(FOIS)评分下降。所有数据,包括mGPS和FOIS,均来自医疗记录。根据FOIS的变化将患者分为“维持”组和“下降”组。还检查了mGPS类别间FOIS得分的差异。进行逻辑回归分析以确定入院时全身性炎症是否是吞咽能力下降的独立危险因素。模型1根据年龄、BMI、军旅结核病和SARC-F≥4进行调整;模型2对年龄、军人结核病和营养不良进行了调整。结果:共纳入119例患者。住院期间,31例患者(26.1%)出现吞咽功能下降。与维持组相比,衰退组明显变老,mGPS评分更高,血清白蛋白更低,老年营养风险指数更低,小腿围更小,行走能力更低,出院时FOIS评分更低。不同mGPS分类患者入院和出院时的FOIS评分差异均有统计学意义(p < 0.01)。吞咽困难(FOIS≤5)的患病率在入院时为12.6% (n=15),出院时为19.3% (n=23)。Logistic回归分析显示,在模型1(优势比2.81,95%可信区间1.28-7.83)和模型2(优势比2.77,95%可信区间1.23-7.71)中,入院时较高的mGPS与住院期间吞咽下降独立相关。结论:住院时的全身性炎症与老年肺结核患者住院期间吞咽困难的发生有关。此外,吞咽困难的患病率从入院时的12.6%上升到出院时的19.3%。
{"title":"Admission systemic inflammation predicts swallowing decline in older adults with pulmonary tuberculosis","authors":"Masayoshi Kakiuchi ,&nbsp;Tatsuro Inoue ,&nbsp;Hikaru Kobayashi ,&nbsp;Aoi Tsukamoto ,&nbsp;Gen Nakano ,&nbsp;Tetsuya Kakehi ,&nbsp;Toshiaki Tanaka ,&nbsp;Masamitsu Nishihara","doi":"10.1016/j.clnesp.2026.102913","DOIUrl":"10.1016/j.clnesp.2026.102913","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Tuberculosis remains a serious infectious disease worldwide. However, the status of swallowing function in older adults with pulmonary tuberculosis and the impact of systemic inflammation on swallowing decline during hospitalization have not been fully elucidated. We aimed to examine whether systemic inflammation at admission affects swallowing function decline in older patients with pulmonary tuberculosis.</div></div><div><h3>Methods</h3><div>This was a single-center, retrospective observational study. The inclusion criteria were patients aged ≥65 years with pulmonary tuberculosis who were admitted to a tuberculosis medical institution between April 2021, and November 2022. Systemic inflammation on admission was assessed with the modified Glasgow Prognostic Score (mGPS). The primary outcome was a decline in swallowing function during hospitalization, defined by a decrease in the Functional Oral Intake Scale (FOIS) score. All data, including mGPS and FOIS, were obtained from medical records. Patients were categorized into a “maintenance” group and a “decline” group based on changes in FOIS. Differences in FOIS scores across mGPS categories were also examined. Logistic regression analyses were performed to identify whether systemic inflammation at admission was an independent risk factor for swallowing decline. Model 1 was adjusted for age, BMI, miliary tuberculosis, and SARC-F ≥4; Model 2 was adjusted for age, miliary tuberculosis, and malnutrition.</div></div><div><h3>Results</h3><div>A total of 119 patients were included in the analysis. During hospitalization, 31 patients (26.1 %) experienced a decline in swallowing function. Compared with the maintenance group, the decline group was significantly older and showed higher mGPS scores, lower serum albumin, lower Geriatric Nutritional Risk Index values, smaller calf circumference, lower walking ability, and lower FOIS scores at discharge. FOIS scores at both admission and discharge significantly differed across mGPS categories (p &lt; 0.01). The prevalence of dysphagia, defined as FOIS ≤5, was 12.6 % (n = 15) at admission and 19.3 % (n = 23) at discharge. Logistic regression analysis revealed that higher mGPS at admission was independently associated with swallowing decline during hospitalization in both Model 1 (odds ratio 2.81, 95 % confidence interval 1.28–7.83) and Model 2 (odds ratio 2.77, 95 % confidence interval 1.23–7.71).</div></div><div><h3>Conclusion</h3><div>Systemic inflammation at admission was associated with the development of dysphagia during hospitalization among older adults with pulmonary tuberculosis. Moreover, the prevalence of dysphagia increased from 12.6 % at admission to 19.3 % at discharge.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102913"},"PeriodicalIF":2.6,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of nutrition in prostate cancer risk, progression, and mortality: A comprehensive review 营养在前列腺癌风险、进展和死亡率中的作用:一项综合综述。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-09 DOI: 10.1016/j.clnesp.2026.102914
Ariela A. Souroujon Torun , Vinaik Sundaresan , Aleksandra Golos , Michael S. Leapman , Olga A. Gomez-Santamaría , Marianne Casilla-Lennon

Background

Prostate cancer (PCa) is one of the most prevalent malignancies among men worldwide, yet evidence-based nutritional recommendations for its prevention and progression remain limited. Growing research indicates that diet may play a significant role in modulating PCa risk, tumor behavior, and mortality.

Objective

This narrative review synthesizes current evidence on major dietary components, including carbohydrates, protein sources, fats, vegetables, vitamins, and minerals. It evaluates their associations with PCa incidence, progression, and disease-specific mortality.

Methods

This narrative review synthesized evidence from PubMed/MEDLINE, Embase, and Web of Science (up to 2025), including randomized trials, observational studies, and meta-analyses, to evaluate associations between dietary factors and prostate cancer incidence, progression, and mortality.

Findings

High intake of simple sugars and refined carbohydrates is associated with elevated PCa risk, whereas complex carbohydrates are associated with a more favorable metabolic profile. Evidence consistently supports increased fish consumption and suggests potential benefit from soy products. In contrast, high intake of red/processed meats and full-fat dairy may increase the risk of aggressive disease. Total and saturated fat intake is associated with poorer outcomes, although evidence on omega-3 fatty acids is mixed. Cruciferous vegetables show a strong protective factor, supported by epidemiologic data, whereas evidence for allium vegetables is emerging. Findings for micronutrients were highly heterogeneous: lycopene and physiologic vitamin E levels may confer benefit, whereas high-dose vitamin A derivatives, supplemental folic acid, selenium, and excessive dairy-derived calcium may increase PCa risk.

Conclusion

Although evidence is often inconsistent, several dietary patterns appear promising for PCa prevention and decreasing mortality. Emphasizing complex carbohydrates, fish, soy, plant-based fats, and cruciferous vegetables—while limiting simple sugars, red/processed meats, whole milk, saturated fats, and unnecessary supplementation—may support improved outcomes. High-quality randomized trials remain urgently needed to clarify causality and refine clinical nutrition guidance for PCa.
背景:前列腺癌(PCa)是世界范围内男性中最常见的恶性肿瘤之一,然而基于证据的预防和进展的营养建议仍然有限。越来越多的研究表明,饮食可能在调节前列腺癌风险、肿瘤行为和死亡率方面发挥重要作用。目的:本综述综合了目前关于主要膳食成分的证据,包括碳水化合物、蛋白质来源、脂肪、蔬菜、维生素和矿物质。它评估了它们与PCa发病率、进展和疾病特异性死亡率的关系。方法:本文综合了PubMed/MEDLINE、Embase和Web of Science(截至2025年)的证据,包括随机试验、观察性研究和荟萃分析,以评估饮食因素与前列腺癌发病率、进展和死亡率之间的关系。研究结果:大量摄入单糖和精制碳水化合物与前列腺癌风险升高相关,而复杂碳水化合物与更有利的代谢特征相关。证据一致支持增加鱼类消费,并表明豆制品的潜在益处。相反,大量摄入红肉/加工肉类和全脂乳制品可能会增加患侵袭性疾病的风险。总脂肪和饱和脂肪的摄入与较差的结果有关,尽管有关ω -3脂肪酸的证据好坏参半。十字花科蔬菜显示出强有力的保护作用,流行病学数据支持,而葱属蔬菜的证据正在出现。微量营养素的研究结果是高度不一致的:番茄红素和生理性维生素E水平可能带来益处,而高剂量的维生素A衍生物、补充叶酸、硒和过量的乳源性钙可能增加前列腺癌的风险。结论:尽管证据往往不一致,但几种饮食模式似乎有望预防前列腺癌并降低死亡率。强调复合碳水化合物、鱼、大豆、植物性脂肪和十字花科蔬菜,同时限制单糖、红/加工肉类、全脂牛奶、饱和脂肪和不必要的补充剂,可能有助于改善结果。目前迫切需要高质量的随机试验来阐明前列腺癌的因果关系和完善临床营养指导。
{"title":"The role of nutrition in prostate cancer risk, progression, and mortality: A comprehensive review","authors":"Ariela A. Souroujon Torun ,&nbsp;Vinaik Sundaresan ,&nbsp;Aleksandra Golos ,&nbsp;Michael S. Leapman ,&nbsp;Olga A. Gomez-Santamaría ,&nbsp;Marianne Casilla-Lennon","doi":"10.1016/j.clnesp.2026.102914","DOIUrl":"10.1016/j.clnesp.2026.102914","url":null,"abstract":"<div><h3>Background</h3><div>Prostate cancer (PCa) is one of the most prevalent malignancies among men worldwide, yet evidence-based nutritional recommendations for its prevention and progression remain limited. Growing research indicates that diet may play a significant role in modulating PCa risk, tumor behavior, and mortality.</div></div><div><h3>Objective</h3><div>This narrative review synthesizes current evidence on major dietary components, including carbohydrates, protein sources, fats, vegetables, vitamins, and minerals. It evaluates their associations with PCa incidence, progression, and disease-specific mortality.</div></div><div><h3>Methods</h3><div>This narrative review synthesized evidence from PubMed/MEDLINE, Embase, and Web of Science (up to 2025), including randomized trials, observational studies, and meta-analyses, to evaluate associations between dietary factors and prostate cancer incidence, progression, and mortality.</div></div><div><h3>Findings</h3><div>High intake of simple sugars and refined carbohydrates is associated with elevated PCa risk, whereas complex carbohydrates are associated with a more favorable metabolic profile. Evidence consistently supports increased fish consumption and suggests potential benefit from soy products. In contrast, high intake of red/processed meats and full-fat dairy may increase the risk of aggressive disease. Total and saturated fat intake is associated with poorer outcomes, although evidence on omega-3 fatty acids is mixed. Cruciferous vegetables show a strong protective factor, supported by epidemiologic data, whereas evidence for allium vegetables is emerging. Findings for micronutrients were highly heterogeneous: lycopene and physiologic vitamin E levels may confer benefit, whereas high-dose vitamin A derivatives, supplemental folic acid, selenium, and excessive dairy-derived calcium may increase PCa risk.</div></div><div><h3>Conclusion</h3><div>Although evidence is often inconsistent, several dietary patterns appear promising for PCa prevention and decreasing mortality. Emphasizing complex carbohydrates, fish, soy, plant-based fats, and cruciferous vegetables—while limiting simple sugars, red/processed meats, whole milk, saturated fats, and unnecessary supplementation—may support improved outcomes. High-quality randomized trials remain urgently needed to clarify causality and refine clinical nutrition guidance for PCa.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102914"},"PeriodicalIF":2.6,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the gut microbiome in childhood obesity: Mechanistic insights and community-based interventions 肠道微生物组在儿童肥胖中的作用:机制见解和社区干预。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-09 DOI: 10.1016/j.clnesp.2026.102911
Truong Ngoc Tham , Ngo Thi Lan Huong , Quach Nhat Kim , Nguyen Thi Diem Kieu , Nguyen Tien Huy
Childhood obesity remains a critical issue, yet traditional efforts focusing on diet and exercise have failed. This review proposes that gut microbiota dysbiosis is not an association, but rather a potentially causal and actionable mechanism underlying childhood obesity. An altered gut microbiome, defined by diminished diversity and specific changes, such as a higher Firmicutes/Bacteroidetes ratio, is a primary contributor to excess weight because of its ability to enhance energy overconsumption, dysregulate production of short-chain fatty acids, regulate appetite, and induce chronic low-grade inflammation. This overview seeks to provide a synthesis of mechanistic evidence and controversies of the gut microbiome as a targetable leverage point, by assessing the microbial signatures of obesity and reflect on the evidence to date and what it implies about the effort: A quest for a singular “obesity microbe” is unlikely to provide success. The unexplained complexity of the host and environment, the lack of a high-quality standard, and evidence of functional microbial pathways and metabolites provide a more fruitful focus. Among other things, this article suggests using high-fiber, whole food dietary strategies to modify the microbiome, the targeted use of evidence-based multi-strain probiotics, and designing school and public health policies to create protective microbiome public health policies. The childhood obesity demands that future efforts focus on the integration of large, multi-omic, longitudinal studies, and the implementation of high-fidelity long-term randomized controlled trial designs that establish the causative relationships, uniform structure to the protocols and enable the implementation of high-impact, equity-based, scalable precision nutrition methodologies.
儿童肥胖仍然是一个严重的问题,然而注重饮食和锻炼的传统努力已经失败。这篇综述提出肠道菌群失调不是一种关联,而是儿童肥胖的潜在因果和可操作机制。肠道微生物群的改变,由多样性的减少和特定的变化定义,如厚壁菌门/杆菌门比例的增加,是超重的主要原因,因为它能够增加能量过度消耗,失调短链脂肪酸的产生,调节食欲,并诱发慢性低度炎症。本综述旨在通过评估肥胖的微生物特征,并反思迄今为止的证据及其所暗示的努力,提供肠道微生物组作为可靶向杠杆点的机制证据和争议的综合:寻求单一的“肥胖微生物”不太可能取得成功。宿主和环境无法解释的复杂性,缺乏高质量的标准,以及功能性微生物途径和代谢物的证据提供了一个更富有成效的焦点。除此之外,本文建议使用高纤维,全食物饮食策略来改变微生物组,有针对性地使用循证多菌株益生菌,并设计学校和公共卫生政策来创建保护性微生物组公共卫生政策。儿童肥胖需要未来的努力集中在大型、多组学、纵向研究的整合上,并实施高保真的长期随机对照试验设计,以建立因果关系,统一方案结构,并使实施高影响、公平、可扩展的精确营养方法成为可能。
{"title":"The role of the gut microbiome in childhood obesity: Mechanistic insights and community-based interventions","authors":"Truong Ngoc Tham ,&nbsp;Ngo Thi Lan Huong ,&nbsp;Quach Nhat Kim ,&nbsp;Nguyen Thi Diem Kieu ,&nbsp;Nguyen Tien Huy","doi":"10.1016/j.clnesp.2026.102911","DOIUrl":"10.1016/j.clnesp.2026.102911","url":null,"abstract":"<div><div>Childhood obesity remains a critical issue, yet traditional efforts focusing on diet and exercise have failed. This review proposes that gut microbiota dysbiosis is not an association, but rather a potentially causal and actionable mechanism underlying childhood obesity. An altered gut microbiome, defined by diminished diversity and specific changes, such as a higher Firmicutes/Bacteroidetes ratio, is a primary contributor to excess weight because of its ability to enhance energy overconsumption, dysregulate production of short-chain fatty acids, regulate appetite, and induce chronic low-grade inflammation. This overview seeks to provide a synthesis of mechanistic evidence and controversies of the gut microbiome as a targetable leverage point, by assessing the microbial signatures of obesity and reflect on the evidence to date and what it implies about the effort: A quest for a singular “obesity microbe” is unlikely to provide success. The unexplained complexity of the host and environment, the lack of a high-quality standard, and evidence of functional microbial pathways and metabolites provide a more fruitful focus. Among other things, this article suggests using high-fiber, whole food dietary strategies to modify the microbiome, the targeted use of evidence-based multi-strain probiotics, and designing school and public health policies to create protective microbiome public health policies. The childhood obesity demands that future efforts focus on the integration of large, multi-omic, longitudinal studies, and the implementation of high-fidelity long-term randomized controlled trial designs that establish the causative relationships, uniform structure to the protocols and enable the implementation of high-impact, equity-based, scalable precision nutrition methodologies.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102911"},"PeriodicalIF":2.6,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Obesity and risk of post-operative pneumonia among older adult patients with hip fracture: An obesity paradox" [Clin Nutr ESPEN 68 (2025) 342-347]. “老年髋部骨折患者的肥胖与术后肺炎风险:肥胖悖论”[临床医学杂志,68(2025)342-347]。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-08 DOI: 10.1016/j.clnesp.2025.102904
Masao Narita, Ryutaro Matsugaki, Keiji Muramatsu, Kiyohide Fushimi, Shinya Matsuda
{"title":"Corrigendum to \"Obesity and risk of post-operative pneumonia among older adult patients with hip fracture: An obesity paradox\" [Clin Nutr ESPEN 68 (2025) 342-347].","authors":"Masao Narita, Ryutaro Matsugaki, Keiji Muramatsu, Kiyohide Fushimi, Shinya Matsuda","doi":"10.1016/j.clnesp.2025.102904","DOIUrl":"https://doi.org/10.1016/j.clnesp.2025.102904","url":null,"abstract":"","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"102904"},"PeriodicalIF":2.6,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145942801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnic differences in thiamine status persist after adjusting for diet; findings from the UK National Diet and Nutrition Survey 饮食调整后,硫胺素水平的种族差异仍然存在;英国国家饮食和营养调查的结果。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-08 DOI: 10.1016/j.clnesp.2025.102893
Albert Koulman , Kerry S. Jones , David Collins , Damon Parkington , Birdem Amoutzopoulos , Polly Page , Nita G. Forouhi

Background/objectives

Thiamine (vitamin B1) status might play a role in cognition and mental health. Recent research suggests that there are ethnic differences in thiamine status. We aimed to test the hypothesis that black individuals have a higher risk of thiamine deficiency than white individuals, based on the erythrocyte transketolase activity coefficient (ETKAC), and assess differences in thiamine intake, using nutritional survey data.

Methods

We used the published data of the UK's National Diet and Nutrition Survey Rolling programme (2008–2019) and examined differences in the ETKAC between ethnicities and risk of thiamine deficiency (ETKAC >1.25). We also used dietary data to determine differences in thiamine intake between ethnic groups.

Results

Within the NDNS 2008–2019 ETKAC measurements were available for 5657 participants (5170 white, 92 black, 228 Asian, 93 mixed and 74 other ethnic groups). The median ETKAC of black participants was higher (1.15 (0.08) median (IQR)) than white (1.10 (0.07)) or Asian (1.12 (0.08)), indicating poorer thiamine status among black participants. The prevalence of thiamine deficiency was 5 % among black participants, being greater than among white (0.5 %) and Asian participants (1.3 %). This was independent of age, sex, body composition and socio-economic status. Dietary assessment data suggested that thiamine intake was on average lower for black participants compared to white or Asian participants Including dietary intake into the model was not sufficient to correct for the ethnic difference in thiamine status.

Conclusions

This study suggests that there are ethnic differences in thiamine status that cannot be readily explained by intake alone.
背景/目的:硫胺素(维生素B1)状态可能在认知和心理健康中发挥作用。最近的研究表明,在硫胺素水平上存在种族差异。基于红细胞转酮酶活性系数(ETKAC),我们旨在验证黑人比白人有更高硫胺素缺乏症风险的假设,并使用营养调查数据评估硫胺素摄入量的差异。方法:我们使用英国国家饮食和营养调查Rolling计划(2008-2019)的已发表数据,并检查种族之间ETKAC和硫胺素缺乏症风险的差异(ETKAC > 1.25)。我们还使用饮食数据来确定不同种族间硫胺素摄入量的差异。结果:在NDNS 2008-2019年的ETKAC测量中,5657名参与者(5170名白人,92名黑人,228名亚洲人,93名混合人种和74名其他种族)可获得测量结果。黑人参与者的ETKAC中位数(1.15(0.08)中位数(IQR))高于白人(1.10(0.07))或亚洲人(1.12(0.08)),表明黑人参与者的硫胺素状态较差。在黑人参与者中,硫胺素缺乏症的患病率为5%,高于白人(0.5%)和亚洲参与者(1.3%)。这与年龄、性别、身体组成和社会经济地位无关。饮食评估数据表明,与白人或亚洲参与者相比,黑人参与者的硫胺素摄入量平均较低,将饮食摄入量纳入模型不足以纠正硫胺素状况的种族差异。结论:本研究表明,不同种族的人在硫胺素水平上存在差异,这不能简单地用摄入量来解释。
{"title":"Ethnic differences in thiamine status persist after adjusting for diet; findings from the UK National Diet and Nutrition Survey","authors":"Albert Koulman ,&nbsp;Kerry S. Jones ,&nbsp;David Collins ,&nbsp;Damon Parkington ,&nbsp;Birdem Amoutzopoulos ,&nbsp;Polly Page ,&nbsp;Nita G. Forouhi","doi":"10.1016/j.clnesp.2025.102893","DOIUrl":"10.1016/j.clnesp.2025.102893","url":null,"abstract":"<div><h3>Background/objectives</h3><div>Thiamine (vitamin B1) status might play a role in cognition and mental health. Recent research suggests that there are ethnic differences in thiamine status. We aimed to test the hypothesis that black individuals have a higher risk of thiamine deficiency than white individuals, based on the erythrocyte transketolase activity coefficient (ETKAC), and assess differences in thiamine intake, using nutritional survey data.</div></div><div><h3>Methods</h3><div>We used the published data of the UK's National Diet and Nutrition Survey Rolling programme (2008–2019) and examined differences in the ETKAC between ethnicities and risk of thiamine deficiency (ETKAC &gt;1.25). We also used dietary data to determine differences in thiamine intake between ethnic groups.</div></div><div><h3>Results</h3><div>Within the NDNS 2008–2019 ETKAC measurements were available for 5657 participants (5170 white, 92 black, 228 Asian, 93 mixed and 74 other ethnic groups). The median ETKAC of black participants was higher (1.15 (0.08) median (IQR)) than white (1.10 (0.07)) or Asian (1.12 (0.08)), indicating poorer thiamine status among black participants. The prevalence of thiamine deficiency was 5 % among black participants, being greater than among white (0.5 %) and Asian participants (1.3 %). This was independent of age, sex, body composition and socio-economic status. Dietary assessment data suggested that thiamine intake was on average lower for black participants compared to white or Asian participants Including dietary intake into the model was not sufficient to correct for the ethnic difference in thiamine status.</div></div><div><h3>Conclusions</h3><div>This study suggests that there are ethnic differences in thiamine status that cannot be readily explained by intake alone.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102893"},"PeriodicalIF":2.6,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to 'Modulation of ceramides through nutrition: A new target in obesity and insulin resistance (Narrative Review)' [Clin Nutr ESPEN 71 (2026) 102836]. “神经酰胺通过营养调节:肥胖和胰岛素抵抗的新靶点(叙事评论)”的更正[临床营养学ESPEN 71(2026) 102836]。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-08 DOI: 10.1016/j.clnesp.2025.102890
Ana T Arias-Marroquín, Ivan Torre-Villalvazo, Omar Granados Portillo, Mariana Villegas-Romero, Alberto Camacho-Morales, Armando R Tovar, Carlos A Aguilar Salinas, Daniel Illescas-Zárate, Natalia Vázquez-Manjarrez
{"title":"Corrigendum to 'Modulation of ceramides through nutrition: A new target in obesity and insulin resistance (Narrative Review)' [Clin Nutr ESPEN 71 (2026) 102836].","authors":"Ana T Arias-Marroquín, Ivan Torre-Villalvazo, Omar Granados Portillo, Mariana Villegas-Romero, Alberto Camacho-Morales, Armando R Tovar, Carlos A Aguilar Salinas, Daniel Illescas-Zárate, Natalia Vázquez-Manjarrez","doi":"10.1016/j.clnesp.2025.102890","DOIUrl":"10.1016/j.clnesp.2025.102890","url":null,"abstract":"","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":" ","pages":"102890"},"PeriodicalIF":2.6,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145942789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of soybean oil lipid emulsion on clinical outcomes in critically ill pediatric patients 大豆油脂乳对危重儿科患者临床结局的影响。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-07 DOI: 10.1016/j.clnesp.2026.102907
Yuki Yamano , Yoshiyuki Shimizu , Yu Inata , Takeshi Hatachi , Yuri Etani

Background & aims

Lipid emulsions are key components of parenteral nutrition (PN); however, concerns persist that soybean oil–based lipid emulsions may increase the risk of infection and catheter occlusion. In pediatric intensive care settings, evidence on the safety of these emulsions remains limited. This study investigated the impact of soybean oil–based lipid emulsion on central venous catheter–related complications and clinical outcomes in children receiving PN in a pediatric intensive care unit (PICU).

Methods

We conducted a single-center retrospective study of children admitted to the PICU between 2018 and 2023 who underwent PN for >7 days. Patients who received PN before PICU admission were excluded. Of the 4589 PICU admissions, 172 patients were included and divided into two groups based on soybean oil–based lipid emulsion administration: 67 patients received the lipid emulsion, and 105 did not. The primary outcomes were catheter occlusion and central line–associated bloodstream infection (CLABSI). Secondary outcomes included duration of mechanical ventilation, length of stay in the PICU, and mortality. Catheter-level analysis was also performed to evaluate the complication rates and catheter survival based on lipid emulsion exposure.

Results

At the patient level, catheter occlusion occurred in 4.5 % of the lipid emulsion–treated group and 2.9 % of the non-treated group (p = 0.68), whereas CLABSI occurred in 7.5 % of the lipid emulsion–treated group and 3.8 % of the non-treated group (p = 0.31), with no significant differences. In the catheter–level analysis, the incidence of CLABSI per 1000 catheter–days was 2.69 in the treated group and 1.40 in the non-treated group (p = 0.30). No significant differences were observed in catheter survival or complication rates.

Conclusion

Soybean oil–based lipid emulsions administered via a central venous catheter did not increase the risk of catheter occlusion nor of CLABSI in critically ill pediatric patients. These findings support the safe use of soybean oil–based intravenous lipid emulsions in PICUs when enteral nutrition is not feasible.
背景与目的:脂质乳剂是肠外营养(PN)的关键成分;然而,人们仍然担心豆油基脂质乳剂可能会增加感染和导管阻塞的风险。在儿科重症监护环境中,关于这些乳剂安全性的证据仍然有限。本研究探讨了豆油为基础的脂质乳剂对在儿科重症监护病房(PICU)接受PN的儿童中心静脉导管相关并发症和临床结果的影响。方法:我们进行了一项单中心回顾性研究,研究对象是2018年至2023年间入住PICU、接受PN治疗bb70天的儿童。排除PICU入院前接受过PN的患者。在4589例PICU入院患者中,纳入172例患者,并根据大豆油为基础的脂质乳治疗分为两组:67例患者接受脂质乳治疗,105例患者未接受脂质乳治疗。主要结局是导管阻塞和中心线相关血流感染(CLABSI)。次要结局包括机械通气时间、PICU住院时间和死亡率。导管水平分析也用于评估基于脂质乳暴露的并发症发生率和导管存活率。结果:在患者水平上,脂质乳剂治疗组和非治疗组的导管闭塞率分别为4.5%和2.9% (p = 0.68),而脂质乳剂治疗组和非治疗组的CLABSI发生率分别为7.5%和3.8% (p = 0.31),差异无统计学意义。在导管水平分析中,治疗组CLABSI发生率为2.69 / 1000导管日,未治疗组为1.40 / 1000导管日(p = 0.30)。两组的导管存活率和并发症发生率无显著差异。结论:通过中心静脉导管给药的豆油基脂质乳不会增加危重儿科患者导管闭塞和CLABSI的风险。这些发现支持在肠内营养不可行的情况下,在picu中安全使用豆油为基础的静脉注射脂质乳剂。
{"title":"Impact of soybean oil lipid emulsion on clinical outcomes in critically ill pediatric patients","authors":"Yuki Yamano ,&nbsp;Yoshiyuki Shimizu ,&nbsp;Yu Inata ,&nbsp;Takeshi Hatachi ,&nbsp;Yuri Etani","doi":"10.1016/j.clnesp.2026.102907","DOIUrl":"10.1016/j.clnesp.2026.102907","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Lipid emulsions are key components of parenteral nutrition (PN); however, concerns persist that soybean oil–based lipid emulsions may increase the risk of infection and catheter occlusion. In pediatric intensive care settings, evidence on the safety of these emulsions remains limited. This study investigated the impact of soybean oil–based lipid emulsion on central venous catheter–related complications and clinical outcomes in children receiving PN in a pediatric intensive care unit (PICU).</div></div><div><h3>Methods</h3><div>We conducted a single-center retrospective study of children admitted to the PICU between 2018 and 2023 who underwent PN for &gt;7 days. Patients who received PN before PICU admission were excluded. Of the 4589 PICU admissions, 172 patients were included and divided into two groups based on soybean oil–based lipid emulsion administration: 67 patients received the lipid emulsion, and 105 did not. The primary outcomes were catheter occlusion and central line–associated bloodstream infection (CLABSI). Secondary outcomes included duration of mechanical ventilation, length of stay in the PICU, and mortality. Catheter-level analysis was also performed to evaluate the complication rates and catheter survival based on lipid emulsion exposure.</div></div><div><h3>Results</h3><div>At the patient level, catheter occlusion occurred in 4.5 % of the lipid emulsion–treated group and 2.9 % of the non-treated group (p = 0.68), whereas CLABSI occurred in 7.5 % of the lipid emulsion–treated group and 3.8 % of the non-treated group (p = 0.31), with no significant differences. In the catheter–level analysis, the incidence of CLABSI per 1000 catheter–days was 2.69 in the treated group and 1.40 in the non-treated group (p = 0.30). No significant differences were observed in catheter survival or complication rates.</div></div><div><h3>Conclusion</h3><div>Soybean oil–based lipid emulsions administered via a central venous catheter did not increase the risk of catheter occlusion nor of CLABSI in critically ill pediatric patients. These findings support the safe use of soybean oil–based intravenous lipid emulsions in PICUs when enteral nutrition is not feasible.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102907"},"PeriodicalIF":2.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145942792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical nutrition ESPEN
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1